All Articles

With its new Hegent carry-on, LEVEL8 blends aerospace-grade materials and a lifetime warranty to disrupt the premium luggage market at a startling price point.

Starton Therapeutics heads to a key investor conference not with a new molecule, but a new method. Can their delivery tech turn old drugs into new blockbusters?

As high rates and uncertainty plague the housing sector, Evergreen Home Loans makes a bold move, appointing a top strategist to overhaul its construction lending.

With private equity backing and a new CEO, GDS Associates is poised for aggressive growth. But can it scale without losing its 40-year-old soul?

As Centuri Holdings prepares for a key investor conference, its new leadership team must address pressing margin concerns while pitching a long-term growth story.

VensureHR’s new Direct Care offering isn't just another benefit. It’s a systemic shift, pushing a disruptive healthcare model into the corporate mainstream.

Third Arc Bio's move to fund clinical development for a new cancer drug validates Adagene's SAFEbody platform, de-risking its finances and setting the stage.

A veteran team from Blue Sea Capital launches Reefline, a new PE firm doubling down on a proven playbook for aerospace, defense, and industrial growth.

Frazier Life Sciences just closed a $1.1B+ oversubscribed fund. This isn't just another raise; it's a masterclass in navigating biotech volatility.

A new report reveals how AI firms use equity to win the talent war. From multi-million dollar packages to new board structures, compensation is shaping innovation.

A new survey reveals a stark reality: 25 years after 9/11, our office buildings remain vulnerable. Explore why old tech fails and how AI is finally making physical spaces truly secure.

With its new Navigator platform, RealNex is moving beyond CRM, introducing an AI-powered suite to make brokerage knowledge measurable, visible, and actionable.

A landmark partnership fuses clean energy ambitions with next-gen defense, as one breakthrough laser technology aims to deliver both fusion power and a shield against new airborne threats.

The oncology firm's revenue dips and losses widen, but a strategic shift to hospitals and key regulatory wins may pave the way for long-term growth.

AI cameras see fatigue on the road, but what if the risk is present before the trip begins? A new approach shifts safety from reactive to truly proactive.

With $45M in projected Q3 revenue, AIT is pursuing a risky deSPAC. Can its pivot to US-made drones and defense tech justify the gamble?

Beyond vibrant festivals, San Antonio's 'Spirit Season' reveals a powerful strategy for weaving cultural authenticity with profound economic and community impact.

Wounded Warrior Project's new campaign goes beyond awareness, tackling the isolation crisis that claims 17 veterans daily. Can one conversation change a life?

As MUSSO targets France with its E80 Muse chair, we unpack the strategy. It’s a tale of cultural timing, niche ergonomics, and aesthetic ambition.

A federal report reveals Canada can't track why kids quit sports. A new platform aims to build the data backbone needed to move beyond compliance and rebuild trust.